Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.690
-0.040 (-2.31%)
At close: Apr 2, 2026, 4:00 PM EDT
1.745
+0.055 (3.26%)
After-hours: Apr 2, 2026, 7:59 PM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $2.41 million as of April 2, 2026. Its market cap has decreased by -49.33% in one year.
Market Cap
2.41M
Enterprise Value
-3.41M
1-Year Change
-49.33%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.33M to $2.41M, a decrease of -90.84%. That is a compound annual growth rate of -26.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.41M | -58.84% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.55M | 131.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 3.24M |
| Galmed Pharmaceuticals | 3.22M |
| Matinas BioPharma Holdings | 3.20M |
| Calidi Biotherapeutics | 2.64M |
| Oragenics | 2.43M |
| 60 Degrees Pharmaceuticals | 2.25M |
| Propanc Biopharma | 2.22M |
| Clearmind Medicine | 2.17M |